NIH-funded research NIH-funded research

Bionomics, Ecology, & Control of Anopheles stephensi using AI-powered traps

Official title: Area B Transmission

Funded at University of Florida · NIH-11507439 · Data updated 2026-11-12

A multi-project effort to understand malaria-carrying mosquitoes and test new AI-enabled traps and rapid testing tools to reduce malaria risk in Africa.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Florida
NIH-funded
Lab location1 site (Gainesville, United States)
Project startApril 22, 2024
Project endMarch 31, 2029
Funding year2026
Award (this year)$22,937
NIH project number3U19AI181594-03S1
Project IDNIH-11507439 on NIH RePORTER

Who could benefit from this research

Could help

Ideal participants are people living in malaria-endemic regions where Anopheles mosquitoes are present, especially urban and peri-urban communities.

Less likely to help

People in regions without malaria transmission or where vector control is not being implemented may see limited direct benefit.

What this research studies

This grant aims to study malaria vectors, improve methods to identify mosquito species, and detect insecticide resistance in real-world settings. Researchers will test field-ready MALDI-MS tech and an artificial intelligence–driven smart trap to monitor Anopheles stephensi and other vectors. The work will be conducted in Nigeria, Cameroon, and other parts of Sub-Saharan Africa to help prevent malaria from resurging in crowded urban areas. The project emphasizes practical tools that can be deployed in communities to support early warning and vector control efforts.

Why it matters

Potential benefit: If successful, communities could see earlier detection of resistant mosquitoes and smarter tools to reduce malaria transmission.

How similar studies have gone: Previous work shows promise for MALDI-MS and AI-driven traps in species identification and monitoring, but this project expands to field deployment and resistance insights.

Where this research is happening

  • University of Florida
    Gainesville, United States
    Active

Researchers

  • Principal investigator: Dinglasan, Rhoel David Ramos — University of Florida
  • Study coordinator: Dinglasan, Rhoel David Ramos

Related research

Other NIH-funded projects on the same topics.

  • Mitochondrial pores and muscle loss in cancer cachexia

    A small US-based study will explore how changes in mitochondria contribute to muscle wasting in people with cancer cachexia and how this may be slowed.

    NIH research University of Florida · Gainesville, United States · NIH-11636110

  • Photobiomodulation for jaw pain from TMD

    A clinician-scientist at the University of Florida is testing a light-based therapy to help adults with temporomandibular disorder pain feel better and jaw function improve.

    NIH research University of Florida · Gainesville, United States · NIH-11635590

  • How the brain controls swallowing and airway protection

    A research team at the University of Florida is studying how brain networks control swallowing to reduce risk of choking and lung infections in people with neuromuscular diseases.

    NIH research University of Florida · Gainesville, United States · NIH-11630949

  • Donor-driven 3D organoid platform to study pancreatic cancer drug response

    A pilot project to create patient-derived, 3D organoid models of pancreatic cancer to measure how tumors from different people respond to chemotherapy.

    NIH research University of Florida · Gainesville, United States · NIH-11625599

  • RAAS inhibitors and pancreatic cancer risk in diverse adults

    A Florida-based study will look at whether commonly used blood pressure medicines (RAAS inhibitors) are linked to new cases of pancreatic cancer, especially among Black and Hispanic adults.

    NIH research University of Florida · Gainesville, United States · NIH-11625597

  • Pilot project exploring new cancer drugs for pancreatic cancer in African American patients

    A small, early-stage project tests new drug-derived compounds to treat pancreatic cancer, focusing on African American patients who are disproportionately affected.

    NIH research University of Florida · Gainesville, United States · NIH-11625594

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.